首页> 外国专利> METHOD FOR TREATING PULMONARY DISEASE STATES IN MAMMALS BY ALTERING INDIGENOUS IN VIVO.

METHOD FOR TREATING PULMONARY DISEASE STATES IN MAMMALS BY ALTERING INDIGENOUS IN VIVO.

机译:通过改变体内土著来治疗哺乳动物的肺部疾病的方法。

摘要

The present invention pertains to a method for treating a pulmonary disease state in mammals by altering indigenous in vivo levels of nitric oxide in mammalian cells. The method comprises contacting the mammalian cells with a therapeutically effective amount of a nitric oxide mediator selected from the group consisting of pyruvates, pyruvate precursors, alpha-keto acids having four or more carbon atoms, precursors of alpha-keto acids having four or more carbon atoms, and the salts thereof. The method further comprises contacting the mammalian cells with a therapeutic agent and a nitric oxide source selected from the group consisting of nitric oxide, nitric oxide precursors, and nitric oxide stimulators. In another embodiment, the method comprises treating a pulmonary disease state in mammals by protecting indigenous in vivo levels of nitric oxide in mammalian cells during ozone inhalation by contacting the mammalian cells with a therapeutically effective amount of a nitric oxide mediator.
机译:本发明涉及通过改变哺乳动物细胞中体内一氧化氮的体内体内水平来治疗哺乳动物的肺部疾病的方法。该方法包括使哺乳动物细胞与治疗有效量的一氧化氮介质接触,所述一氧化氮介质选自丙酮酸盐,丙酮酸盐前体,具有四个或更多个碳原子的α-酮酸,具有四个或更多个碳的α-酮酸的前体。原子及其盐。该方法进一步包括使哺乳动物细胞与治疗剂和选自由一氧化氮,一氧化氮前体和一氧化氮刺激剂组成的组的一氧化氮源接触。在另一个实施方案中,该方法包括通过使哺乳动物细胞与治疗有效量的一氧化氮介体接触来保护臭氧吸入期间哺乳动物细胞中的体内一氧化氮水平,从而治疗哺乳动物的肺部疾病状态。

著录项

  • 公开/公告号MXPA04000993A

    专利类型

  • 公开/公告日2004-04-20

    原文格式PDF

  • 申请/专利权人 CELLULAR SCIENCES INC.;

    申请/专利号MX2004PA00993

  • 发明设计人 ALAIN MARTIN;

    申请日2002-08-15

  • 分类号A61K31/19;A61K31/195;A61K31/215;

  • 国家 MX

  • 入库时间 2022-08-21 23:09:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号